456 related articles for article (PubMed ID: 22658977)
1. Clozapine decreases exploratory activity and increases anxiety-like behaviour in the Wistar-Kyoto rat but not the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder.
Mc Fie S; Sterley TL; Howells FM; Russell VA
Brain Res; 2012 Jul; 1467():91-103. PubMed ID: 22658977
[TBL] [Abstract][Full Text] [Related]
2. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
Howells FM; Russell VA
Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
[TBL] [Abstract][Full Text] [Related]
3. Evidence for reduced tonic levels of GABA in the hippocampus of an animal model of ADHD, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2013 Dec; 1541():52-60. PubMed ID: 24161405
[TBL] [Abstract][Full Text] [Related]
4. Nicotine-stimulated release of [3H]norepinephrine is reduced in the hippocampus of an animal model of attention-deficit/hyperactivity disorder, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2014 Jul; 1572():1-10. PubMed ID: 24833064
[TBL] [Abstract][Full Text] [Related]
5. Maternal separation increases GABA(A) receptor-mediated modulation of norepinephrine release in the hippocampus of a rat model of ADHD, the spontaneously hypertensive rat.
Sterley TL; Howells FM; Russell VA
Brain Res; 2013 Feb; 1497():23-31. PubMed ID: 23276497
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
[TBL] [Abstract][Full Text] [Related]
7. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists.
Langen B; Dost R
Atten Defic Hyperact Disord; 2011 Mar; 3(1):1-12. PubMed ID: 21432613
[TBL] [Abstract][Full Text] [Related]
8. Genetically determined differences in noradrenergic function: The spontaneously hypertensive rat model.
Sterley TL; Howells FM; Russell VA
Brain Res; 2016 Jun; 1641(Pt B):291-305. PubMed ID: 26612520
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
[TBL] [Abstract][Full Text] [Related]
10. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
Warton FL; Howells FM; Russell VA
Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
[TBL] [Abstract][Full Text] [Related]
11. Increased glutamate-stimulated norepinephrine release from prefrontal cortex slices of spontaneously hypertensive rats.
Russell VA; Wiggins TM
Metab Brain Dis; 2000 Dec; 15(4):297-304. PubMed ID: 11383554
[TBL] [Abstract][Full Text] [Related]
12. Effects of early life trauma are dependent on genetic predisposition: a rat study.
Sterley TL; Howells FM; Russell VA
Behav Brain Funct; 2011 May; 7():11. PubMed ID: 21548935
[TBL] [Abstract][Full Text] [Related]
13. Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
van den Bergh FS; Bloemarts E; Chan JS; Groenink L; Olivier B; Oosting RS
Pharmacol Biochem Behav; 2006 Mar; 83(3):380-90. PubMed ID: 16580713
[TBL] [Abstract][Full Text] [Related]
14. Region-specific elevation of D₁ receptor-mediated neurotransmission in the nucleus accumbens of SHR, a rat model of attention deficit/hyperactivity disorder.
Ohno Y; Okano M; Masui A; Imaki J; Egawa M; Yoshihara C; Tatara A; Mizuguchi Y; Sasa M; Shimizu S
Neuropharmacology; 2012 Sep; 63(4):547-54. PubMed ID: 22580374
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
Soeters HS; Howells FM; Russell VA
Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
[TBL] [Abstract][Full Text] [Related]
16. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
Ueno K; Togashi H; Yoshioka M
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and neurochemical effects of acute putrescine depletion by difluoromethylornithine in rats.
Gupta N; Zhang H; Liu P
Neuroscience; 2009 Jul; 161(3):691-706. PubMed ID: 19348875
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine or behavioral effects of acute or chronic emotional stress in Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats.
Roman O; Seres J; Pometlova M; Jurcovicova J
Endocr Regul; 2004 Dec; 38(4):151-5. PubMed ID: 15841794
[TBL] [Abstract][Full Text] [Related]
19. Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD.
Li JS; Huang YC
Behav Brain Res; 2006 Nov; 175(1):176-82. PubMed ID: 16979765
[TBL] [Abstract][Full Text] [Related]
20. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
